ESTABLISHMENT LABS HOLDINGS INC. (ESTA) Form 8-K — Oct 29, 2026
Establishment Labs reported Q3 2026 revenue of $72.0 million, up 33.9% year over year, driven by 119% U.S. growth to $26.0 million and 124% growth in its minimally invasive platform to roughly $9 million. The company achieved its first-ever quarter of positive operating cash flow (~$7.7M) and free cash flow ($5.1M), while Adjusted EBITDA rose to $6.4 million from $1.2 million a year ago. GAAP net loss narrowed to $10.7 million ($(0.35) per share).
Key figures
- Revenue
- 72000000
- Guidance
- FY2026 revenue raised to more than $274 million (from $269-271M); adjusted gross margin ~70.7%; adjusted opex $195-200M; positive adjusted EBITDA; FY2027 growth expected at 25% with positive cash flow
- Total Debt
- 267820000
- Revenue Yoy
- 33.9%
- Cash Position
- 75812000
- Us revenue
- $26.0M, +119.0% YoY
- Ous revenue
- $46.0M, +9.7% YoY
- Free cash flow
- $5.1M — first positive quarter in company history
- Adjusted ebitda
- $6.4M (8.9% of revenue) vs $1.2M prior year
- Operating cash flow
- ~$7.7M
- Adjusted gross margin
- 70.8%
- Us commercial accounts
- more than 2,100 accounts
- Minimally invasive revenue
- ~$9M, +124% YoY
- Surgeons trained on preserve
- more than 400
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.